Pyng Medical Corp

Saving lives by saving time through innovation in resuscitation®

Pyng Announces Terms of Private Placement

May 27th, 2009

May 25, 2009, Vancouver, BC – Further to its press release dated May 14, 2009
announcing the terms of a non-brokered private placement (the “Private Placement”)
secured subordinated convertible notes (“Notes”), Pyng Medical Corp. (the “Company”)
(TSX-V: PYT) announces that the conversion price of the Notes has now been fixed at
$0.20 per unit and the Private Placement will consist of up to $1 million aggregate
principal amount of Notes.

All other terms of the Private Placement remain as outlined in the Company’s press
released dated May 14, 2009.

The Private Placement is subject to the negotiation, execution and delivery of definitive
agreements and the receipt of applicable regulatory approvals including approval of the
TSX Venture Exchange.

About Pyng Medical Corp.
Pyng is a leader in resuscitation innovation with simple-to-use and highly effective
products including FAST1® Intraosseous Infusion System, the FASTx™ System, T-POD®
Pelvic Stabilizer, and MAT® Tourniquet. The Company is awaiting FDA approval of the
CRIC Cricothyrotomy System which is currently under final development. The
Company plans to submit an application for FDA approval of the FASTx™ System which is
currently still under development.

For More Information

Bob DiSilvio
Pyng Medical Corp.
(604) 303-7964
www.pyng.com

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.